+
Site Tour

Search

Showing 91 - 100 of 430 results.

  • Diagnosis

    AF AND STROKE ARE OFTEN CONNECTED MORE SEVERE FIND OUT MORE: PATIENTS WHO BENEFIT Clinical Data

  • Clinical Data

    SWITCH TO THE REFERRAL VIEW    For more information specific to neurology regarding PFO closure  FIND OUT MORE: DOWNLOAD ESOC PRESENTATION Download data summary  Downloa

  • Guidelines

    Summary of the current guidelines PMR SMR ESC/EACTS – GUIDELINES FOR THE MANAGEMENT OF VALVULAR HEART DISEASE (2021)16 N/A TMVR is also emer

  • EPIC™ Max Features

    PORCINE LEAFLETS LOW AORTIC PROTRUSION UNIQUE PERICARDIAL S

  • EPIC™ MAX Patients who benefit

    © Abbott 2025. All rights reserved. 9-EH-5-14980-01 02-2025 REV B

  • Overview

    SWITCH TO THE interventional VIEW    For more information specific to interventional cardiology regarding PDA closure If PDA is left untreated, the mortality rate is 20% by age 20 years,

  • Clinical Data

    EXCELLENT OUTCOMES IN CLINICAL TRIAL RESULTS FIND OUT MORE: Clinical trials  CLINICAL INSIGHTS 30-DAY NAVITOR™1,2 N=120 EVOLUT‡ PRO3 N=60 ACURATE NEO2‡4

  • Treatment

    Patients may also receive a remote monitoring system which allows them to transmit data to the doctor without an in-office visit. CLASS II Slight limitation of physical activity. Comfortable at re

  • Diagnosis

    Figure 1: The diagnostic algorithm for heart failure. BNP=B-type natriuretic peptide; ECG=electrocardiogram; HFmrEF=heart failure with mildly reduced ejection fraction; HFpEF=heart failure with pres

  • Diagnosis

    Characteristics that are strongly associated with a causal role of PFO in an ischemic stroke of unknown cause are:9 Atrial septal aneurysm (ASA) and/or a moderate-to-severe shunt Atrial septal

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline